Remove Competition Remove Healthcare Provider Remove Manufacturing
article thumbnail

Competition in Healthcare is Increasing—Rapidly and Dramatically

Healthcare Success

Whether you represent a hospital, health system, or multilocation practice, competing healthcare businesses are developing innovative business models—right now—and they’re targeting your market. What’s more, your highest revenue service lines are likely already facing stiff competition from all angles. . The answer is twofold.

article thumbnail

Patent expiration to drive biosimilars market expansion to 2032

European Pharmaceutical Review

Expirations of biologic patents has enabled manufacturers to enter the market and offer lower-cost alternatives of these drugs, according to the report. This has resulted in “increased competition and price pressure, driving the growth of the biosimilar market”. million by 2032, at 17.6 percent CAGR between 2023 and 2032.

Marketing 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma Marketing Keyword Research for PPC

Pharma Marketing Network

Competition for High-Value Keywords Branded drug names and general medical terms attract intense competition. Generic drug manufacturers, healthcare providers, and wellness brands often bid on similar terms. Regulatory restrictions, high keyword competition, and audience segmentation make keyword research complex.

article thumbnail

The Ripple Effect: How Recent U.S. Tariffs Will Impact Medical Device Sales and Manufacturing in 2025

Legacy MEDSearch

The medical device industry has long been a globalized ecosystem, with raw materials, components, and finished products crisscrossing international supply chains before reaching healthcare providers. based manufacturers relying on imported parts. A core objective of these tariffs is to bring more manufacturing back to the U.S.,

article thumbnail

ESG in pharma: Meeting increasing requirements in the Nordic region

Pharmaceutical Technology

Nordic healthcare providers are leading the momentum in enhancing ESG considerations. We examine the regional developments that will provide a competitive edge to pharma manufacturers.

Pharma 52
article thumbnail

Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets

PM360

In 2017, Algeria imposed importation restrictions on medicinal products that could be manufactured domestically, forcing manufacturers to establish local manufacturing facilities or to work with a contract manufacturing organization (CMO). Firstly, entering new markets and increasing sales should boost revenue.

article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed. Medicines manufacturing is energy intensive.